Global 7-Aminocephalosporanic Acid (7-ACA) 麻豆原创 Growth 2025-2031

Publication ID:

LPI04250396

Publication Date:

April 17, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global 7-Aminocephalosporanic Acid (7-ACA) market size is predicted to grow from US$ 784 million in 2025 to US$ 1159 million in 2031; it is expected to grow at a CAGR of 6.7% from 2025 to 2031.
7-ACA (7-aminocephalosporanic acid) is the core chemical structure (a synthon) for the synthesis of cephalosporin antibiotics and intermediates. It can be obtained by chemoenzymatic hydrolysis of cephalosporin C.
7-Aminocephalosporanic acid (7-ACA) is a key intermediate of cephalosporin antibiotics and is used to synthesize a variety of semi-synthetic cephalosporin antibiotics.
The major manufacturers in the global 7-ACA market include Yili Chuannig Biotechnology, Joincare Pharmaceutical, CSPC Pharmaceutical Group, Sinopharm Weiqida Pharma, Changsheng Pharmaceutical, CordenPharma, Dragon Pharma and Nectar Lifesciences, which accounted for a major share of the global market in 2022.
China is the world's largest market, accounting for about 34% in 2023. The main manufacturers in China include Yili Chuannig Biotechnology, Joincare Pharmaceutical, CSPC Pharmaceutical Group and Sinopharm Weiqida Pharma.
In terms of product types, 7-ACA is mainly divided into enzymatic hydrolysis and chemical cleavage. The application areas mainly include the production of cephalosporin antibiotics such as ceftriaxone, cefazolin, ceftazidime and cefotaxime.
Overall, the 7-ACA market benefits from the steady growth of downstream cephalosporin antibiotic demand and is expected to continue to grow in the next few years.
The 鈥�7-Aminocephalosporanic Acid (7-ACA) Industry Forecast鈥� looks at past sales and reviews total world 7-Aminocephalosporanic Acid (7-ACA) sales in 2024, providing a comprehensive analysis by region and market sector of projected 7-Aminocephalosporanic Acid (7-ACA) sales for 2025 through 2031. With 7-Aminocephalosporanic Acid (7-ACA) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 7-Aminocephalosporanic Acid (7-ACA) industry.
This Insight Report provides a comprehensive analysis of the global 7-Aminocephalosporanic Acid (7-ACA) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 7-Aminocephalosporanic Acid (7-ACA) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global 7-Aminocephalosporanic Acid (7-ACA) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 7-Aminocephalosporanic Acid (7-ACA) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 7-Aminocephalosporanic Acid (7-ACA).
This report presents a comprehensive overview, market shares, and growth opportunities of 7-Aminocephalosporanic Acid (7-ACA) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Enzymatic Hydrolysis
Chemical Cracking
Segmentation by Application:
Ceftriaxone
Cefazolin
Ceftazidime
Cefotaxime
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Yili Chuangning Biotechnology
Joincare Pharmaceutical Group Industry Co.,Ltd.
CSPC Pharmaceutical Group Limited
Sinopharm Weiqida Pharmaceutical Co.,Led.
INNER MONGOLIA Changsheng Pharmaceutical Co., Ltd.
CordenPharma
Dragon Pharma
Nectar Lifesciences
Key Questions Addressed in this Report
What is the 10-year outlook for the global 7-Aminocephalosporanic Acid (7-ACA) market?
What factors are driving 7-Aminocephalosporanic Acid (7-ACA) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do 7-Aminocephalosporanic Acid (7-ACA) market opportunities vary by end market size?
How does 7-Aminocephalosporanic Acid (7-ACA) break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global 7-Aminocephalosporanic Acid (7-ACA) Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for 7-Aminocephalosporanic Acid (7-ACA) by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for 7-Aminocephalosporanic Acid (7-ACA) by Country/Region, 2020, 2024 & 2031
2.2 7-Aminocephalosporanic Acid (7-ACA) Segment by Type
2.2.1 Enzymatic Hydrolysis
2.2.2 Chemical Cracking
2.3 7-Aminocephalosporanic Acid (7-ACA) Sales by Type
2.3.1 Global 7-Aminocephalosporanic Acid (7-ACA) Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global 7-Aminocephalosporanic Acid (7-ACA) Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global 7-Aminocephalosporanic Acid (7-ACA) Sale Price by Type (2020-2025)
2.4 7-Aminocephalosporanic Acid (7-ACA) Segment by Application
2.4.1 Ceftriaxone
2.4.2 Cefazolin
2.4.3 Ceftazidime
2.4.4 Cefotaxime
2.5 7-Aminocephalosporanic Acid (7-ACA) Sales by Application
2.5.1 Global 7-Aminocephalosporanic Acid (7-ACA) Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global 7-Aminocephalosporanic Acid (7-ACA) Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global 7-Aminocephalosporanic Acid (7-ACA) Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global 7-Aminocephalosporanic Acid (7-ACA) Breakdown Data by Company
3.1.1 Global 7-Aminocephalosporanic Acid (7-ACA) Annual Sales by Company (2020-2025)
3.1.2 Global 7-Aminocephalosporanic Acid (7-ACA) Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global 7-Aminocephalosporanic Acid (7-ACA) Annual Revenue by Company (2020-2025)
3.2.1 Global 7-Aminocephalosporanic Acid (7-ACA) Revenue by Company (2020-2025)
3.2.2 Global 7-Aminocephalosporanic Acid (7-ACA) Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global 7-Aminocephalosporanic Acid (7-ACA) Sale Price by Company
3.4 Key Manufacturers 7-Aminocephalosporanic Acid (7-ACA) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers 7-Aminocephalosporanic Acid (7-ACA) Product Location Distribution
3.4.2 Players 7-Aminocephalosporanic Acid (7-ACA) Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for 7-Aminocephalosporanic Acid (7-ACA) by Geographic Region
4.1 World Historic 7-Aminocephalosporanic Acid (7-ACA) 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global 7-Aminocephalosporanic Acid (7-ACA) Annual Sales by Geographic Region (2020-2025)
4.1.2 Global 7-Aminocephalosporanic Acid (7-ACA) Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic 7-Aminocephalosporanic Acid (7-ACA) 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global 7-Aminocephalosporanic Acid (7-ACA) Annual Sales by Country/Region (2020-2025)
4.2.2 Global 7-Aminocephalosporanic Acid (7-ACA) Annual Revenue by Country/Region (2020-2025)
4.3 Americas 7-Aminocephalosporanic Acid (7-ACA) Sales Growth
4.4 APAC 7-Aminocephalosporanic Acid (7-ACA) Sales Growth
4.5 Europe 7-Aminocephalosporanic Acid (7-ACA) Sales Growth
4.6 Middle East & Africa 7-Aminocephalosporanic Acid (7-ACA) Sales Growth
5 Americas
5.1 Americas 7-Aminocephalosporanic Acid (7-ACA) Sales by Country
5.1.1 Americas 7-Aminocephalosporanic Acid (7-ACA) Sales by Country (2020-2025)
5.1.2 Americas 7-Aminocephalosporanic Acid (7-ACA) Revenue by Country (2020-2025)
5.2 Americas 7-Aminocephalosporanic Acid (7-ACA) Sales by Type (2020-2025)
5.3 Americas 7-Aminocephalosporanic Acid (7-ACA) Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC 7-Aminocephalosporanic Acid (7-ACA) Sales by Region
6.1.1 APAC 7-Aminocephalosporanic Acid (7-ACA) Sales by Region (2020-2025)
6.1.2 APAC 7-Aminocephalosporanic Acid (7-ACA) Revenue by Region (2020-2025)
6.2 APAC 7-Aminocephalosporanic Acid (7-ACA) Sales by Type (2020-2025)
6.3 APAC 7-Aminocephalosporanic Acid (7-ACA) Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe 7-Aminocephalosporanic Acid (7-ACA) by Country
7.1.1 Europe 7-Aminocephalosporanic Acid (7-ACA) Sales by Country (2020-2025)
7.1.2 Europe 7-Aminocephalosporanic Acid (7-ACA) Revenue by Country (2020-2025)
7.2 Europe 7-Aminocephalosporanic Acid (7-ACA) Sales by Type (2020-2025)
7.3 Europe 7-Aminocephalosporanic Acid (7-ACA) Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa 7-Aminocephalosporanic Acid (7-ACA) by Country
8.1.1 Middle East & Africa 7-Aminocephalosporanic Acid (7-ACA) Sales by Country (2020-2025)
8.1.2 Middle East & Africa 7-Aminocephalosporanic Acid (7-ACA) Revenue by Country (2020-2025)
8.2 Middle East & Africa 7-Aminocephalosporanic Acid (7-ACA) Sales by Type (2020-2025)
8.3 Middle East & Africa 7-Aminocephalosporanic Acid (7-ACA) Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of 7-Aminocephalosporanic Acid (7-ACA)
10.3 Manufacturing Process Analysis of 7-Aminocephalosporanic Acid (7-ACA)
10.4 Industry Chain Structure of 7-Aminocephalosporanic Acid (7-ACA)
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 7-Aminocephalosporanic Acid (7-ACA) Distributors
11.3 7-Aminocephalosporanic Acid (7-ACA) Customer
12 World Forecast Review for 7-Aminocephalosporanic Acid (7-ACA) by Geographic Region
12.1 Global 7-Aminocephalosporanic Acid (7-ACA) 麻豆原创 Size Forecast by Region
12.1.1 Global 7-Aminocephalosporanic Acid (7-ACA) Forecast by Region (2026-2031)
12.1.2 Global 7-Aminocephalosporanic Acid (7-ACA) Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global 7-Aminocephalosporanic Acid (7-ACA) Forecast by Type (2026-2031)
12.7 Global 7-Aminocephalosporanic Acid (7-ACA) Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Yili Chuangning Biotechnology
13.1.1 Yili Chuangning Biotechnology Company Information
13.1.2 Yili Chuangning Biotechnology 7-Aminocephalosporanic Acid (7-ACA) Product Portfolios and Specifications
13.1.3 Yili Chuangning Biotechnology 7-Aminocephalosporanic Acid (7-ACA) Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Yili Chuangning Biotechnology Main Business Overview
13.1.5 Yili Chuangning Biotechnology Latest Developments
13.2 Joincare Pharmaceutical Group Industry Co.,Ltd.
13.2.1 Joincare Pharmaceutical Group Industry Co.,Ltd. Company Information
13.2.2 Joincare Pharmaceutical Group Industry Co.,Ltd. 7-Aminocephalosporanic Acid (7-ACA) Product Portfolios and Specifications
13.2.3 Joincare Pharmaceutical Group Industry Co.,Ltd. 7-Aminocephalosporanic Acid (7-ACA) Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Joincare Pharmaceutical Group Industry Co.,Ltd. Main Business Overview
13.2.5 Joincare Pharmaceutical Group Industry Co.,Ltd. Latest Developments
13.3 CSPC Pharmaceutical Group Limited
13.3.1 CSPC Pharmaceutical Group Limited Company Information
13.3.2 CSPC Pharmaceutical Group Limited 7-Aminocephalosporanic Acid (7-ACA) Product Portfolios and Specifications
13.3.3 CSPC Pharmaceutical Group Limited 7-Aminocephalosporanic Acid (7-ACA) Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 CSPC Pharmaceutical Group Limited Main Business Overview
13.3.5 CSPC Pharmaceutical Group Limited Latest Developments
13.4 Sinopharm Weiqida Pharmaceutical Co.,Led.
13.4.1 Sinopharm Weiqida Pharmaceutical Co.,Led. Company Information
13.4.2 Sinopharm Weiqida Pharmaceutical Co.,Led. 7-Aminocephalosporanic Acid (7-ACA) Product Portfolios and Specifications
13.4.3 Sinopharm Weiqida Pharmaceutical Co.,Led. 7-Aminocephalosporanic Acid (7-ACA) Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Sinopharm Weiqida Pharmaceutical Co.,Led. Main Business Overview
13.4.5 Sinopharm Weiqida Pharmaceutical Co.,Led. Latest Developments
13.5 INNER MONGOLIA Changsheng Pharmaceutical Co., Ltd.
13.5.1 INNER MONGOLIA Changsheng Pharmaceutical Co., Ltd. Company Information
13.5.2 INNER MONGOLIA Changsheng Pharmaceutical Co., Ltd. 7-Aminocephalosporanic Acid (7-ACA) Product Portfolios and Specifications
13.5.3 INNER MONGOLIA Changsheng Pharmaceutical Co., Ltd. 7-Aminocephalosporanic Acid (7-ACA) Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 INNER MONGOLIA Changsheng Pharmaceutical Co., Ltd. Main Business Overview
13.5.5 INNER MONGOLIA Changsheng Pharmaceutical Co., Ltd. Latest Developments
13.6 CordenPharma
13.6.1 CordenPharma Company Information
13.6.2 CordenPharma 7-Aminocephalosporanic Acid (7-ACA) Product Portfolios and Specifications
13.6.3 CordenPharma 7-Aminocephalosporanic Acid (7-ACA) Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 CordenPharma Main Business Overview
13.6.5 CordenPharma Latest Developments
13.7 Dragon Pharma
13.7.1 Dragon Pharma Company Information
13.7.2 Dragon Pharma 7-Aminocephalosporanic Acid (7-ACA) Product Portfolios and Specifications
13.7.3 Dragon Pharma 7-Aminocephalosporanic Acid (7-ACA) Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Dragon Pharma Main Business Overview
13.7.5 Dragon Pharma Latest Developments
13.8 Nectar Lifesciences
13.8.1 Nectar Lifesciences Company Information
13.8.2 Nectar Lifesciences 7-Aminocephalosporanic Acid (7-ACA) Product Portfolios and Specifications
13.8.3 Nectar Lifesciences 7-Aminocephalosporanic Acid (7-ACA) Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Nectar Lifesciences Main Business Overview
13.8.5 Nectar Lifesciences Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.